Exothera Nucleic Acids Strengthens Team with Industry Expert
New Chief Technology Officer will help to accelerate the delivery of high-quality development and manufacturing services for the next generation of RNA therapiesDr. Patrick Thiaville, CTO of Exothera Nucleic AcidsPictured: Dr. Patrick Thiaville, CTO of Exothera Nucleic Acids. To download image, please click here.Brussels, Belgium, May 9, 2023 – Life Science Newswire – Exothera Nucleic Acids, the w
12 May 2023